These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol. Sitbon O; McLaughlin VV; Badesch DB; Barst RJ; Black C; Galiè N; Humbert M; Rainisio M; Rubin LJ; Simonneau G Thorax; 2005 Dec; 60(12):1025-30. PubMed ID: 16055621 [TBL] [Abstract][Full Text] [Related]
31. Pulmonary artery hypertension in heart transplant recipients: how much is too much? De Santo LS; Romano G; Maiello C; Buonocore M; Cefarelli M; Galdieri N; Nappi G; Amarelli C Eur J Cardiothorac Surg; 2012 Nov; 42(5):864-9; discussion 869-70. PubMed ID: 22402452 [TBL] [Abstract][Full Text] [Related]
32. Successful cardiac transplantation in a patient with elevated pulmonary vascular resistance: a relative contraindication to transplantation. Morris CD; Smith RD; Kar B; Ghodsizad A; Reverdin S; Frazier OH; Gregoric ID Heart Surg Forum; 2009 Jan; 12(1):E59-60. PubMed ID: 19233769 [TBL] [Abstract][Full Text] [Related]
33. Inhaled milrinone and epoprostenol in a patient with severe pulmonary hypertension, right ventricular failure, and reduced baseline brain saturation value from a left atrial myxoma. St-Pierre P; Deschamps A; Cartier R; Basmadjian AJ; Denault AY J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):723-9. PubMed ID: 23623891 [No Abstract] [Full Text] [Related]
34. Up-front combination therapy in pulmonary arterial hypertension: from clinical trials to 'real world' observational studies. Grignola JC Int J Cardiol; 2014 May; 173(3):349-50. PubMed ID: 24698227 [TBL] [Abstract][Full Text] [Related]
35. Left ventricular assist device or heart transplantation: impact of transpulmonary gradient and pulmonary vascular resistance on decision making. Mikus E; Stepanenko A; Krabatsch T; Dandel M; Lehmkuhl HB; Loforte A; Hetzer R; Potapov EV Eur J Cardiothorac Surg; 2011 Mar; 39(3):310-6. PubMed ID: 20615720 [TBL] [Abstract][Full Text] [Related]
36. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure. Reddy MT; Patel H; Ventura HO Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294 [No Abstract] [Full Text] [Related]
37. [Severe refractory pulmonary hypertension after liver transplantation for hepatitis C liver cirrhosis]. Dietrich CG; Gartung C; Siewert E; Lammert F; Matern S; Geier A Z Gastroenterol; 2006 Jan; 44(1):33-7. PubMed ID: 16397837 [TBL] [Abstract][Full Text] [Related]
38. Epoprostenol treatment in children with severe pulmonary hypertension. Lammers AE; Hislop AA; Flynn Y; Haworth SG Heart; 2007 Jun; 93(6):739-43. PubMed ID: 17065181 [TBL] [Abstract][Full Text] [Related]
39. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566 [TBL] [Abstract][Full Text] [Related]